Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Cytology-based Detection of Circulating Tumour Cells in Human Pancreatic Cancer Xenograft Models With KRAS Mutation

YUKAKO ITO, ERIKO INOUE, YUKI MATSUI, SHINJI KOBUCHI, CHIAMI MOYAMA, KIKUKO AMAGASE, MAYUMI YOSHIMURA, YUZURU IKEHARA, SUSUMU NAKATA and HAYAO NAKANISHI
Anticancer Research December 2020, 40 (12) 6781-6789; DOI: https://doi.org/10.21873/anticanres.14701
YUKAKO ITO
1Department of Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yukako{at}mb.kyoto-phu.ac.jp
ERIKO INOUE
1Department of Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKI MATSUI
1Department of Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINJI KOBUCHI
1Department of Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIAMI MOYAMA
2Department of Clinical Oncology, Kyoto Pharmaceutical University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KIKUKO AMAGASE
3Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAYUMI YOSHIMURA
4Department of Gastroenterological Surgery, Graduate School of Medicine, Nagoya University, Aichi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUZURU IKEHARA
5Department of Molecular and Tumor Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUSUMU NAKATA
2Department of Clinical Oncology, Kyoto Pharmaceutical University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HAYAO NAKANISHI
4Department of Gastroenterological Surgery, Graduate School of Medicine, Nagoya University, Aichi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 12 6781-6789
DOI 
https://doi.org/10.21873/anticanres.14701
PMID 
33288571

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 11, 2020
  • Revision received October 8, 2020
  • Accepted October 9, 2020
  • Published online December 7, 2020.

Copyright & Usage 
Copyright © 2020 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. YUKAKO ITO⇑1,
  2. ERIKO INOUE1,
  3. YUKI MATSUI1,
  4. SHINJI KOBUCHI1,
  5. CHIAMI MOYAMA2,
  6. KIKUKO AMAGASE3,
  7. MAYUMI YOSHIMURA4,
  8. YUZURU IKEHARA5,
  9. SUSUMU NAKATA2 and
  10. HAYAO NAKANISHI4
  1. 1Department of Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto, Japan
  2. 2Department of Clinical Oncology, Kyoto Pharmaceutical University, Kyoto, Japan
  3. 3Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan
  4. 4Department of Gastroenterological Surgery, Graduate School of Medicine, Nagoya University, Aichi, Japan
  5. 5Department of Molecular and Tumor Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan
  1. Correspondence to: Yukako Ito, Ph.D., Department of Pharmacokinetics, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto, 607-8412, Japan. Tel: +81 755954626, Fax: +81 755956311, e-mail: yukako{at}mb.kyoto-phu.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 12
December 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cytology-based Detection of Circulating Tumour Cells in Human Pancreatic Cancer Xenograft Models With KRAS Mutation
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Cytology-based Detection of Circulating Tumour Cells in Human Pancreatic Cancer Xenograft Models With KRAS Mutation
YUKAKO ITO, ERIKO INOUE, YUKI MATSUI, SHINJI KOBUCHI, CHIAMI MOYAMA, KIKUKO AMAGASE, MAYUMI YOSHIMURA, YUZURU IKEHARA, SUSUMU NAKATA, HAYAO NAKANISHI
Anticancer Research Dec 2020, 40 (12) 6781-6789; DOI: 10.21873/anticanres.14701

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Cytology-based Detection of Circulating Tumour Cells in Human Pancreatic Cancer Xenograft Models With KRAS Mutation
YUKAKO ITO, ERIKO INOUE, YUKI MATSUI, SHINJI KOBUCHI, CHIAMI MOYAMA, KIKUKO AMAGASE, MAYUMI YOSHIMURA, YUZURU IKEHARA, SUSUMU NAKATA, HAYAO NAKANISHI
Anticancer Research Dec 2020, 40 (12) 6781-6789; DOI: 10.21873/anticanres.14701
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Prediction System for KRAS Mutation Detection in Circulating Tumor DNA in Unresectable Pancreatic Cancer
  • Google Scholar

More in this TOC Section

  • Ginsenoside Rh4 Induces Apoptosis Through ROS-Mediated Fas Signaling in Human Nasopharyngeal Carcinoma NPC/HK1 Cells
  • Genome-wide Analysis Highlights rs4671908 and rs2238431 as Predictors of Survival in Nasopharyngeal Carcinoma
  • Implications of the Cuproptosis Protein SLC31A1 for the Immune Microenvironment and Temozolomide Sensitivity in Glioblastoma
Show more Experimental Studies

Keywords

  • CTC
  • Pancreatic cancer
  • KRAS mutation
  • mouse model
  • cytology
  • CTC detection platform
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire